Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.1960
-0.0080 (-3.92%)
Oct 27, 2026, 5:35 PM CET
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €14.71 million as of October 27, 2026. It is the 37,947th most valuable company in the world and the 228th biggest in Spain. Its market cap has decreased by 42.12% in one year.
Market Cap
14.71M
Enterprise Value
15.79M
Revenue
3.43M
Global Rank
Country Rank
#228 Spain
PE Ratio
n/a
ChartMarket Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 14.71M, a decrease of -80.29%. That is a compound annual growth rate of -17.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 14.71M | 3.10% |
| Dec 31, 2025 | 14.27M | -21.93% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.38B |
| Laboratorios Farmaceuticos Rovi | 3.14B |
| Almirall | 2.26B |
| Faes Farma | 1.46B |
| Laboratorio Reig Jofre | 214.22M |
| Prim, S.A. | 211.75M |
| Oryzon Genomics | 204.91M |
| Atrys Health | 203.05M |